IBRX
IMMUNITYBIO INC
Health Care·Biotechnology·UNITED STATES
$7.25
MCap $7.6B
as of 2026-06-09
Total
B1w
Fund
C1w
Quant
A1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.82
Sentiment 12.6%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$7.25
Adaptive Mean
$7.06
+0.19 vs mean
Adaptive σ
0.11
MIDOS BB
$6.84 – $7.29
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
-0.73
ROE
—
Z —
Rev Gr
167.6%
Z +1.11
EPS Gr
38.7%
Z +0.07
OPM Gr
59.5%
Z +0.05
FCF Yld
-3.8%
Z -0.15
EPS Surp
-798.6%
Z -5.64
EPS 3mo Δ
-1.7%
Z +0.16
Fwd P/E
120.83
Z —
PEGY
3.12
Expensive
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-4.74
Q6M
11.22
Q12M
4.73
MA 30/100
1.002
Bullish (MA30 > MA100)
α (Jensen)
-0.8484
β (12M)
1.97
σ (12M)
1.048
Divergence — Fundamentals vs Momentum
Z Percentile
6%
Q Percentile
80%
Divergence
-73.9
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
238.7
RS Pctl
99%
RS Decile
D10
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.